AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
2024 Europe Sexually-Transmitted Disease (STD) Testing Market: France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis-
... the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, ... Read More
-
2024 Global Herpes Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for Herpes ... Read More
-
2024 France Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts - AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas Vaginalis
... analysis of the French STD market. Current scientific views on epidemiology and etiology are presented for: AIDS/HIV Chancroid Chlamydia Gonorrhea Granuloma Inguinale Herpes I/II Lymphogranuloma Mycoplasma Papillomavirus Syphilis Trichomonas Vaginalis The report provides test volume ... Read More
-
2024 UK Sexually-Transmitted Disease (STD) Molecular Diagnostics Market: Shares and Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis
... of the U.K. STD market. Current scientific views on epidemiology and etiology are presented for: AIDS/HIV Chancroid Chlamydia Gonorrhea Granuloma Inguinale Herpes I/II Lymphogranuloma Mycoplasma Papillomavirus Syphilis Trichomonas Vaginalis The report provides test volume and ... Read More
-
2024 Germany Sexually-Transmitted Disease (STD) Molecular Diagnostics Market: Shares and Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis
... of the German STD market. Current scientific views on epidemiology and etiology are presented for: AIDS/HIV Chancroid Chlamydia Gonorrhea Granuloma Inguinale Herpes I/II Lymphogranuloma Mycoplasma Papillomavirus Syphilis Trichomonas Vaginalis The report provides test volume and ... Read More
-
2024 Italy Sexually-Transmitted Disease (STD) Molecular Diagnostics Market: Shares and Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis
... of the Italian STD market. Current scientific views on epidemiology and etiology are presented for: AIDS/HIV Chancroid Chlamydia Gonorrhea Granuloma Inguinale Herpes I/II Lymphogranuloma Mycoplasma Papillomavirus Syphilis Trichomonas Vaginalis The report provides test volume and ... Read More
-
2024 USA Sexually-Transmitted Disease (STD) Molecular Diagnostics Market: Shares and Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), Syphilis
... of the US STD market. Current scientific views on epidemiology and etiology are presented for: AIDS/HIVChancroidChlamydiaGonorrheaGranuloma InguinaleHerpes I/IILymphogranulomaMycoplasmaPapillomavirusSyphilisTrichomonas Vaginalis The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to ... Read More
-
Vaccines Market, By Type (Monovalent Vaccines , Multitvalent Vaccines), By Technology (Conjugate Vaccines, Recombinant Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Other Vaccine Technologies), By Disease Indication (Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & ... Read More
-
2024 Europe Sexually-Transmitted Disease (STD) Market: Shares and Segment Forecasts - AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas Vaginalis
... sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the France, Germany, Italy, ... Read More
-
2024 Global Sexually-Transmitted Disease (STD) Market (US, Europe, Japan): Shares and Segment Forecasts - AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, Trichomonas Vagin
... of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the ... Read More
-
Global Genital Herpes Treatment Market - 2024-2031
... during the forecast period 2024-2031. Genital herpes is a sexually transmitted disease (STD) caused by the herpes simplex virus (HSV) especially HSV type 2. It can cause sores in the genital or rectal area, buttocks, ... Read More
-
HIV Treatment Drugs Industry Forecasts - China Focus
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
HIV Treatment Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
HIV Treatment Drugs Markets in China
... Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's ... Read More
-
Home Testing Products Markets in China
... Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's ... Read More
-
Global Human Immunodeficiency Virus (HIV) Type-1 Treatment Market - 2024-2031
... growing at a CAGR of 5.9% during the forecast period 2024-2031. HIV-1 is a retrovirus, belonging to a group of heterogeneous, lipid-enveloped RNA viruses. HIV-1 is the most common type of HIV (Human Immunodeficiency Virus) ... Read More
-
Herpes Marker Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented ... Read More
-
Global Herpes Simplex Virus (HSV) Vaccines Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... provides a comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various ... Read More
-
Herpes Testing Kits Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented ... Read More
-
Herpes Simplex Virus Testing Kits Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major ... Read More
-
Kaposi Sarcoma
... at a CAGR of 3.1% over the analysis period 2023-2030. HAART, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$101.5 Million by the end of the ... Read More
-
Infectious Disease Diagnostics
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion ... Read More
-
Herpes Zoster Treatment
... by 2030, growing at a CAGR of 1.9% over the analysis period 2023-2030. Antiviral Medications, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$134.0 Million by ... Read More
-
2024 Global Forecast for Sexually Transmitted Disease (Std) Diagnosis Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Sexually Transmitted Diseases Testing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
Research Assistance
